Every year, Covance sponsors scientific symposia and webinars, designed to bring together thought-leaders from academia, agile biotech firms and large pharmaceutical companies. The cost for these educational events are minimal in order to encourage learning, networking and sharing.
Wednesday, February 17, 2021 11 a.m. – 2 p.m. EST (NY) / 4 p.m. – 7 p.m. GMT (UK)
Even as one non-alcoholic steatohepatitis (NASH) compound is approaching market approval and many other clinical trials of investigational drugs are underway, treatments for NASH are still urgently required to improve outcomes for a large, global patient population. Addressing this unmet need has been challenging for drug developers, especially with enrollment and execution of NASH trials.
Join our NASH symposium with several specialists and key opinion leaders as they discuss the current issues and latest strategies on advancing NASH clinical trials. Designed for a biopharmaceutical audience as well as treating physicians, each educational track will include time for Q&A with the speakers and there will be a panel discussion with all speakers at the end of the symposium.
Nonclinical Drug Development Symposium
Covance has made the difficult decision to postpone the Nonclinical Drug Development Symposium, 6-7 May 2020, in Germany. We will reconvene the symposium on 5-6 May 2021 at the same location. Registration will reopen in early 2021.